These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8372500

  • 1. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
    Lewis AP, Crowe JS.
    Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
    [No Abstract] [Full Text] [Related]

  • 2. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R.
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract] [Full Text] [Related]

  • 3. The construction of a mouse/human chimeric antibody against human breast cancer cells.
    Meulemans E, Vandevyver C, Volckaert G, Raus J.
    Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
    [No Abstract] [Full Text] [Related]

  • 4. Humanized anti-carcinoembryonic antigen antibody: strategies to enhance human tumor cell killing.
    Kaulen H, Seemann G, Bosslet K, Schwaeble W, Dippold W.
    Year Immunol; 1993; 7():106-9. PubMed ID: 8372499
    [No Abstract] [Full Text] [Related]

  • 5. Recombinant chimeric monoclonal antibodies.
    Morrison SL, Schlom J.
    Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
    [No Abstract] [Full Text] [Related]

  • 6. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH, Reurs A, Roovers RC, Arends JW, Whitelegg NR, Rees AR, Hoogenboom HR.
    J Mol Biol; 2000 Feb 25; 296(3):833-49. PubMed ID: 10677285
    [Abstract] [Full Text] [Related]

  • 7. [Transgenesis and humanization of murine antibodies].
    Cogné M, Duchez S, Pascal V.
    Med Sci (Paris); 2009 Dec 25; 25(12):1149-54. PubMed ID: 20035696
    [Abstract] [Full Text] [Related]

  • 8. Generation of a humanised single chain Fv (Scfv) derived from the monoclonal Eric-1 recognising the human neural cell adhesion molecule.
    Whittington HA, Hancock J, Kemshead JT.
    Med Pediatr Oncol; 2001 Jan 25; 36(1):243-6. PubMed ID: 11464896
    [Abstract] [Full Text] [Related]

  • 9. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC, Cao T.
    Med Hypotheses; 2005 Jan 25; 64(6):1105-8. PubMed ID: 15823695
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK.
    Q J Nucl Med; 1998 Dec 25; 42(4):225-41. PubMed ID: 9973838
    [Abstract] [Full Text] [Related]

  • 11. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H, Nie Y, Huse WD, Watkins JD.
    J Mol Biol; 1999 Nov 19; 294(1):151-62. PubMed ID: 10556035
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of engineered antibodies.
    Hwang WY, Foote J.
    Methods; 2005 May 19; 36(1):3-10. PubMed ID: 15848070
    [Abstract] [Full Text] [Related]

  • 13. Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.
    Krauss J, Arndt MA, Vu BK, Newton DL, Seeber S, Rybak SM.
    Biochem Biophys Res Commun; 2005 Jun 03; 331(2):595-602. PubMed ID: 15850802
    [Abstract] [Full Text] [Related]

  • 14. From rodent reagents to human therapeutics using antibody guided selection.
    Osbourn J, Groves M, Vaughan T.
    Methods; 2005 May 03; 36(1):61-8. PubMed ID: 15848075
    [Abstract] [Full Text] [Related]

  • 15. Antibody humanization by framework shuffling.
    Dall'Acqua WF, Damschroder MM, Zhang J, Woods RM, Widjaja L, Yu J, Wu H.
    Methods; 2005 May 03; 36(1):43-60. PubMed ID: 15848074
    [Abstract] [Full Text] [Related]

  • 16. Designer mice: the production of human antibody repertoires in transgenic animals.
    Brüggemann M, Davies NP, Rosewell IR.
    Year Immunol; 1993 May 03; 7():33-40. PubMed ID: 8372511
    [No Abstract] [Full Text] [Related]

  • 17. Development of humanized antibodies as cancer therapeutics.
    Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM.
    Methods; 2005 May 03; 36(1):84-95. PubMed ID: 15848077
    [Abstract] [Full Text] [Related]

  • 18. Generation and application of a fluorescein-specific single chain antibody.
    Schenk JA, Sellrie F, Böttger V, Menning A, Stöcklein WF, Micheel B.
    Biochimie; 2007 Nov 03; 89(11):1304-11. PubMed ID: 17686564
    [Abstract] [Full Text] [Related]

  • 19. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 Nov 03; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 20. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
    Yang X, Hu W, Li F, Xia H, Zhang Z.
    Protein Expr Purif; 2005 Jun 03; 41(2):341-8. PubMed ID: 15866720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.